Tech Company Financing Transactions
Civitas Therapeutics Funding Round
Canaan Partners and private investors joined a $10 million venture round for Civitas Therapeutics. The funding round closed on 12/31/2011.
Transaction Overview
Company Name
Announced On
12/31/2011
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Canaan Partners (Timothy Shannon)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
190 Everett Ave.
Chelsea, MA 02150
USA
Chelsea, MA 02150
USA
Phone
Website
Email Address
Overview
Civitas is a pharmaceutical company focused on developing products with a clinically proven dry powder pulmonary delivery platform. The proprietary dry powder and device combination is unique in its ability to deliver a large, precise dose independent of inspiratory flow rate from a simple, passive device.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Iwicki
Chief Medical Officer
Martin Freed
Chief Scientific Officer
Rick Batycky
VP - Regulatory Affairs
Mary Taylor
VP - Sales
Bryan Stuart
Browse more venture capital transactions:
Prev: 12/31/2011: Schematic Labs venture capital transaction
Next: 12/31/2011: Xicato venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs